| Name | Taragarestrant |
|---|
| Description | Taragarestrant (D-0502) is a potent, orally active estrogen receptor degrader. Taragarestrant has antiproliferative activity against estrogen receptor-positive breast cancer cell lines and has anticancer activity. Taragarestrant can be used for cancer research[1][2]. |
|---|---|
| Related Catalog | |
| References |
[2]. WHO Drug Information. International Nonproprietary Names for Pharmaceutical |
| Molecular Formula | C25H25Cl2FN2O2 |
|---|---|
| Molecular Weight | 475.38 |